BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Carter CJ, Mekkawy AH, Morris DL. Role of human nucleoside transporters in pancreatic cancer and chemoresistance. World J Gastroenterol 2021; 27(40): 6844-6860 [PMID: 34790010 DOI: 10.3748/wjg.v27.i40.6844]
URL: https://www.wjgnet.com/1948-5204/full/v27/i40/6844.htm
Number Citing Articles
1
Praveen Bhoopathi, Padmanabhan Mannangatti, Swadesh K. Das, Paul B. Fisher, Luni Emdad. Pancreatic Cancer: Basic Mechanisms and TherapiesAdvances in Cancer Research 2023; 159: 285 doi: 10.1016/bs.acr.2023.02.010
2
Tejinder Kaur, Brenna Weadick, Thomas A. Mace, Kajal Desai, Hannah Odom, Rajgopal Govindarajan. Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunitiesPharmacology & Therapeutics 2022; 240: 108300 doi: 10.1016/j.pharmthera.2022.108300
3
Binglin Sui, Junling Chen, Dian Ge, Feng Liang, Hongda Wang. Assembly Characterization of Human Equilibrium Nucleoside Transporter 1 (hENT1) by Inhibitor Probe-Based dSTORM ImagingAnalytical Chemistry 2023; 95(24): 9207 doi: 10.1021/acs.analchem.3c00596
4
Yunchun Zhao, Shuya Ye, Yao Zhu, Yue Chen, Shan Yang, Fengmei Wang, Rong Wang, Dongxu Qin, Dongli Sun, Caihong Zheng. Advancement in transporter-oriented nanoplatforms for cancer therapyJournal of Drug Targeting 2023; 31(5): 456 doi: 10.1080/1061186X.2023.2197570
5
Erika Y. Faraoni, Cynthia Ju, Simon C. Robson, Holger K. Eltzschig, Jennifer M. Bailey-Lundberg. Purinergic and Adenosinergic Signaling in Pancreatobiliary DiseasesFrontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.849258
6
Wesley S. van de Geer, Ron H.J. Mathijssen, Job van Riet, Neeltje Steeghs, Mariette Labots, Carla van Herpen, Lot A. Devriese, Vivianne C.G. Tjan-Heijnen, Emile E. Voest, Stefan Sleijfer, John W.M. Martens, Edwin Cuppen, Harmen J.G. van de Werken, Sander Bins. Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumorsBiomedicine & Pharmacotherapy 2023; 159: 114210 doi: 10.1016/j.biopha.2022.114210
7
Karyl K. Buddington, Stefan G. Pierzynowski, William E. Holmes, Randal K. Buddington. Selective and Concentrative Enteropancreatic Recirculation of Antibiotics by PigsAntibiotics 2023; 13(1): 12 doi: 10.3390/antibiotics13010012
8
Md. Ratul Rahman, Kouji Hirota, Ryotaro Kawasumi. Proofreading exonuclease activity of replicative polymerase epsilon promotes cellular tolerance to arabinosides in CTF18-dependent and -independent mannerGenome Instability & Disease 2024; 5(2): 76 doi: 10.1007/s42764-024-00124-w
9
Nikoleta Iosifidou, Eleni Anagnostopoulou, Maria Botou, Eirini Kalfa, Ekaterini Tatsaki, Stathis Frillingos. Elucidation of the Gemcitabine Transporters of Escherichia coli K-12 and Gamma-Proteobacteria Linked to Gemcitabine-Related ChemoresistanceInternational Journal of Molecular Sciences 2024; 25(13): 7012 doi: 10.3390/ijms25137012
10
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic ReviewCancers 2022; 14(10): 2486 doi: 10.3390/cancers14102486
11
Debasis Nayak, Brenna Weadick, Rajgopal Govindarajan. Cancer Systems and Integrative BiologyMethods in Molecular Biology 2023; 2660: 95 doi: 10.1007/978-1-0716-3163-8_8
12
Renshuai Zhang, Jun Zeng, Wenjing Liu, Jingsen Meng, Chao Wang, Lingyu Shi, Shanbo Yang, Jing Chang, Dongming Xing. The role of NPC1L1 in cancerFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.956619
13
Sara Alam, Emily Doherty, Paula Ortega-Prieto, Julia Arizanova, Louise Fets. Membrane transporters in cell physiology, cancer metabolism and drug responseDisease Models & Mechanisms 2023; 16(11) doi: 10.1242/dmm.050404